1. Home
  2. LEE vs PDSB Comparison

LEE vs PDSB Comparison

Compare LEE & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • PDSB
  • Stock Information
  • Founded
  • LEE 1890
  • PDSB 2005
  • Country
  • LEE United States
  • PDSB United States
  • Employees
  • LEE N/A
  • PDSB N/A
  • Industry
  • LEE Newspapers/Magazines
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • PDSB Health Care
  • Exchange
  • LEE Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • LEE 52.7M
  • PDSB 43.1M
  • IPO Year
  • LEE N/A
  • PDSB N/A
  • Fundamental
  • Price
  • LEE $7.46
  • PDSB $1.20
  • Analyst Decision
  • LEE
  • PDSB Strong Buy
  • Analyst Count
  • LEE 0
  • PDSB 3
  • Target Price
  • LEE N/A
  • PDSB $10.00
  • AVG Volume (30 Days)
  • LEE 15.8K
  • PDSB 203.4K
  • Earning Date
  • LEE 05-08-2025
  • PDSB 05-14-2025
  • Dividend Yield
  • LEE N/A
  • PDSB N/A
  • EPS Growth
  • LEE N/A
  • PDSB N/A
  • EPS
  • LEE N/A
  • PDSB N/A
  • Revenue
  • LEE $591,094,000.00
  • PDSB N/A
  • Revenue This Year
  • LEE N/A
  • PDSB N/A
  • Revenue Next Year
  • LEE N/A
  • PDSB N/A
  • P/E Ratio
  • LEE N/A
  • PDSB N/A
  • Revenue Growth
  • LEE N/A
  • PDSB N/A
  • 52 Week Low
  • LEE $7.57
  • PDSB $0.85
  • 52 Week High
  • LEE $19.63
  • PDSB $4.42
  • Technical
  • Relative Strength Index (RSI)
  • LEE 33.20
  • PDSB 48.97
  • Support Level
  • LEE $7.35
  • PDSB $1.20
  • Resistance Level
  • LEE $8.80
  • PDSB $1.27
  • Average True Range (ATR)
  • LEE 0.45
  • PDSB 0.10
  • MACD
  • LEE -0.05
  • PDSB -0.00
  • Stochastic Oscillator
  • LEE 5.80
  • PDSB 39.27

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: